Homocysteine and its role in the pathogenesis of atherosclerotic vascular disease

Journal of Association of Physicians of India

Volumn 50, Issue 5, 2002, Pages 16-23

  Sainani, G S ^a,b   Sainani, R ^c  

^a GRANT MEDICAL COLLEGE   (India)

^b JASLOK HOSPITAL AND RESEARCH CENTRE   (India)

^c TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ARTERIOSCLEROSIS; CLINICAL TRIAL; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; METABOLISM; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ARTERIOSCLEROSIS; CLINICAL TRIALS; ENDOTHELIUM, VASCULAR; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MUSCLE, SMOOTH, VASCULAR; RISK FACTORS;

EID: 0036560195     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. McCully KS. Vascular pathology of homocysteinemia : Implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56:111-28.
2. Anderson A, Lindgren A, Hultberg B. Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction. Clin Chem 1995;41:361-6.
3. Misra HP. Generation of superoxide free radical during the auto-oxidation of thiols. J Biol Chem 1974;249:3151-5.
4. de Groot PG, Willems C, Boers GH, Consalves MD, van Aken WG, van Mourik JA. Endothelial cell dysfunction in homocysteinuria. Eur J Clin Invest 1993;13:405-10.
5. Harker LA, Slichter SJ, Scott CR, et al. Homocysteinemia : Vascular injury and arterial thrombosis. N Engl J Med 1974;291:537-43.
6. Seshadri N, Robinson K. Homocysteine, B vitamins and coronary artery disease. Med Clin North America 2000;84:215-37.
7. Wall RT, Harlan JM, Harker LA, et al. Homocysteine - induced endothelial cell injury in vitro : a model for the study of vascular injury. Thomb Res 1980;18:113-21.
8. Wu KK, Thiagarajan P. Role of endothelium in thrombosis and hemostasis. Annu Rev Med 1996;47:315-31.
9. Stamler JS, Osborne JA, Jaraki O, et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993;91:308-18.
10. Tawakol A, Omland T, Gerhand M, et al. Hyperhomocysteinemia is associated with impaired endothelium-dependent vasodilatation in humans. Circulation 1997;95:1119-21.
11. Woo KS, Chook P, Lolin Y, et al. Folic acid supplementation improves arterial endothelial function in hyperhomocysteinemic subjects. Circulation 1997;96:2542-4.
12. Poddar R, Sivaenbramanian N, Robinson R, et al. Homocysteinc modules the expression of a specific cytokine (monocyste chemo-attractant protein 1) in human aortic endothelial cells. Circulation 1997;96:1-286.
13. Dudman NPB, Temple SE, Guo XW, Fu WY, Perry MA. Homocysteine enhances neurtrophil-endothelial interactions in both cultured human cells and rats in vivo. Circ Res 1999;84:409-16.
14. Hladovec J. Experimental homocysteinemia, endothelial lesions, and thrombosis. Blood Vessels 1979;18:11-20.
15. Reddy GSR, Wilcken DEL. Experimental homocysteinemia in pigs: Comparison with studies in sixteen homocysteinuric patients. Metabolism 1982;31:778-83.
16. Rolland PH, Friggi A, Barlatier A, et al. Hyperhomocysteinemia-induced vascular damage in the minipig. Captopril-hydrochlorothiazide combination prevents elastic alterations. Circulation 1995;91:1161-74.
17. Van den Berg M, Boers GH, Franken DG, et al. Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. Eur J Clin Invest 1995;25:176-81.
18. Starkebaum G, Harian JM. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1993;77:1370-6.
19. Haynes WG, Guthikanda Sasidhar. Hyperhomocysteine. Asian J Clinical Cardiology 2000;3:14-26.
20. Loscalzo J. The oxidant stress of hyperhomocysteinemia. J Clin Invest 1966;98:5-7.
21. Hughes H, Mathews B, Lenz ML, Guyton JR. Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol. Arterioscler Throm 1994;14:177-85.
22. Heineckle JW, Kawarmura M, Suzuki L, Chait A. Oxidation of low density lipoprotein by thiols : supperoxide - dependent and independent mechanisms. J Lipid Res 1993;33:2051-61.
23. Tsi JC, Wang H, Perrella MA, et al. Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cell. J Clin Invest 1996;97:146-53.
24. Dey SC. Homocysteine : A new risk factor in atherosclerotic vascular disease. Cardiology Today 2000;4:323-5.
25. Fryer RH, Wilson BD, Gubler DB, et al. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb 1993;13:1327-33.
26. Dierkes J, Westphal S, Luley C. Serum homocysteine increases after therapy with fenofibrate or bezafibrate. Lancet 1999;354:219-20.
27. Di Minno G, Davi G, Margaglione M. Abnormally high thromboxane biosynthesis in homozygous homocystinuria : Evidence for platelet involvement and probucol-sensitive mechanism. J Clin Invest 1993;92:1400-6.
28. Majors A, Ehrhart LA, Pezacka EH. Homocysteine as a risk factor for vascular disease : Enhanced collagen production and accumulation by smooth muscle cells. Arterioscler Thromb Vasc Biol 1997;17:2074-81.
29. Mijatovic V, Kenemans P, Netelenbos C, et al. Postmenopausal oral 17 beta-estradiol continuously combined with hydrogesterone reduces fasting serum homocysteine levels. Fertil Steril 1998;69:876-82.
30. Kumbasar SD, Dincer I, Ertas F, et al. Hyper-homocysteinemia and restenosis. J Cardiovasc Risk 2001;8-9:13.
31. Miner Steven ES, Hegele RA, Sparkes J, et al. Interventional Cardiology Homocysteine, lipoprotein, and restenosis after percutaneous translumin coronary angioplasty. Am Heart J 2000;140:272-8.
32. Boushey CJ, Beresford SA, Omen GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intake. JAMA 1995;274:1049-57.
33. Tambe AB. Homocysteine and atherosclerotic vascular disease. Cardiology Today 2000;4:269-71.
34. Wald NJ, Watt HC, Law MR, Weig DG, McPartlin J, Scott JM. Homocysteine and ischaemic heart disease : results of a prospective study with implications on prevention. Arch Intern Med 1998;158:862-7.
35. Sehub J, Jacques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotid artery stenosis. N Engl J Med 1995;332:286-91.
36. Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 1992;268:877-81.
37. Arnesen E, Refsum H, Bona KH, Ueland PM, Forde OH, Nordehaug JE. Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995;24:704-9.
38. Nygard O, Nordrehaug JE, Refsum H, Ueland FM, Farstad M, Vollset SE. Plasma homocysteine level and mortality in patients with coronary artery disease. New Engl J Med 1997;337:230-36.
39. Wilcken DE, Wilcken B. The pathogenesis of coronary artery disease : a possible role for methionine metabolism. J Clin Invest 1976;57:1079-82.
40. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997;277:1775-81.
41. Evans RW, Shaten BJ, Hempel HD, et al. Homocysteine and risk of cardiovascular disease in the Multiple Risk Factor intervention Trial. Arterioscler Thromb Vasc Biol 1997;17:1947-53.
42. Folsom AR, Nieto FJ, McGovern PG, et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins. The Atherosclerosis Risk in Communities (ARIC) study. Circulation 1998;98:204-10.
43. Chacko KA. Plasma Homocysteine levels in patients with coronary heart disease. Ind Heart J 1995.
44. Chambers JC, Obeid OA, Refsum H, et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 2000;355:523-7.
45. McKeigue PM, Ferrie JE, Peirpoint T, Marmot MG. Association of early - onset coronary heart disease in South Asian men with glucose intolerance and hyper-insulinemia. Circulation 1993;87:152-61.
46. Kooner JS. Coronary heart disease in UK Indian Asians - the potential for prevention. Heart 1997;78:530-2.